ALPPL2 is a highly specific and targetable tumor cell surface antigen
Y. Su, X. Zhang, S. Bidlingmaier, C. R. Behrens, N.-K. Lee, B. Liu
The paper identifies ALPPL2 as a highly specific tumor cell surface antigen for mesothelioma and demonstrates its therapeutic potential through an antibody-drug conjugate.
bioRxiv · Jan 7, 2020Cancer Biology